Presentation

Getinge is a global hospital provider of products and systems aiming to improve clinical results and optimise workflows. The offering includes solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs 10,000+ people worldwide and the products are sold in more than 135 countries.

Recent highlights
In Q2, net sales amounted to 6,670M SEK, increased by 84M SEK (+1.3%) but declined organically by 7.5%. The order intake declined organically by 5.0%.
Several new products were launched during H1 2022: Aquadis 56 - innovative mid-sized premium washer-disinfectors; Getinge IN2 - an intelligent solution to create interconnected and efficient workplaces in hospital departments; a single leg holder system for OR tables; an updated version of endoscope washer-disinfector; Vac-a-Scope - a benchtop packaging system, and DPTE-EXO with Sleeveless DPTE-BetaBag.
In March, Getinge was awarded a new 3-year Anesthesia contract from Premier Inc, a healthcare improvement company in the US. In July, Getinge completed the acquisition of FLUOPTICS SAS, a French based leader in fluorescence imaging to aid surgery.

Outlook
The company’s financial targets for 2022-2025 include annual organic net sales growth of 4–6% and adjusted EPS growth of >10% on average. In Q2 2022 presentation, the company disclosed that the organic net sales for 2022 are expected to be in line with reported net sales for 2021.